Literature DB >> 23640178

Intravitreal fasudil combined with bevacizumab for persistent diabetic macular edema: a novel treatment.

Hamid Ahmadieh1, Ramin Nourinia, Ali Hafezi-Moghadam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640178     DOI: 10.1001/jamaophthalmol.2013.143

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  10 in total

Review 1.  Therapeutic Options in Refractory Diabetic Macular Oedema.

Authors:  Sanket U Shah; Raj K Maturi
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 2.  Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology.

Authors:  Nuno Moura-Coelho; Joana Tavares Ferreira; Carolina Pereira Bruxelas; Marco Dutra-Medeiros; João Paulo Cunha; Rita Pinto Proença
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-07       Impact factor: 3.117

3.  Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study.

Authors:  Sahba Fekri; Ramin Nourinia; Babak Rahimi-Ardabili; Arash Daneshtalab; Hamideh Sabbaghi; Hamid Ahmadieh; Bahareh Kheiri
Journal:  Int J Retina Vitreous       Date:  2022-06-11

4.  Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.

Authors:  Gianni Virgili; Mariacristina Parravano; Jennifer R Evans; Iris Gordon; Ersilia Lucenteforte
Journal:  Cochrane Database Syst Rev       Date:  2018-10-16

Review 5.  Novel pharmacotherapies in diabetic retinopathy.

Authors:  Vaidehi S Dedania; Sophie J Bakri
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

6.  Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study.

Authors:  Ramin Nourinia; Hamid Ahmadieh; Mohammad-Hassan Shahheidari; Souska Zandi; Shintaro Nakao; Ali Hafezi-Moghadam
Journal:  J Ophthalmic Vis Res       Date:  2013-10

7.  ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy.

Authors:  Pierre-Raphaël Rothschild; Sawsen Salah; Marianne Berdugo; Emmanuelle Gélizé; Kimberley Delaunay; Marie-Christine Naud; Christophe Klein; Alexandre Moulin; Michèle Savoldelli; Ciara Bergin; Jean-Claude Jeanny; Laurent Jonet; Yvan Arsenijevic; Francine Behar-Cohen; Patricia Crisanti
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

Review 8.  Rho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases.

Authors:  Muneo Yamaguchi; Shintaro Nakao; Mitsuru Arima; Iori Wada; Yoshihiro Kaizu; Feng Hao; Shigeo Yoshida; Koh-Hei Sonoda
Journal:  J Ophthalmol       Date:  2017-05-10       Impact factor: 1.909

9.  Effect of ripasudil on diabetic macular edema.

Authors:  Yoshiro Minami; Young-Seok Song; Akihiro Ishibazawa; Tsuneaki Omae; Tomoko Ro-Mase; Satoshi Ishiko; Akitoshi Yoshida
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

10.  High Glucose Aggravates Retinal Endothelial Cell Dysfunction by Activating the RhoA/ROCK1/pMLC/Connexin43 Signaling Pathway.

Authors:  Hongran Zhao; Hui Kong; Wenjuan Wang; Tianran Chen; Yuting Zhang; Jing Zhu; Dandan Feng; Yan Cui
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.